Article

BEST PRACTICES IN: Oral Cancer Therapies: Important Prescribing Considerations

Sponsored by Novartis Pharmaceuticals

 

A supplement to The Journal of Community and Supportive Oncology. This supplement was sponsored by Novartis Pharmaceuticals.

To view the supplement, click the image to the right

   Comments ()

Recommended for You

News & Commentary

Quizzes from MD-IQ

Research Summaries from ClinicalEdge

Next Article: